Our blog

Interview with Berit Lindholm | CEO | Bluefish Pharmaceuticals
Interview with Berit Lindholm | CEO | Bluefish Pharmaceuticals
by Team Invenia Biopharma
Posted in Biopharma
As part of our ‘Female Leaders: Inspiring Together’ series, we interviewed Berit Lindholm – CEO for Bluefish Pharma – about how she started her career in pharmaceuticals, her greatest achievements and why she initially turned down a CEO role.
Read more
Interview with Lusi Chien | Former Global Commercial Leader | Subtle Medical
Interview with Lusi Chien | Former Global Commercial Leader | Subtle Medical
by Team Invenia Life Sciences
Posted in MedTech & Devices
As part of our ‘Female Leaders: Inspiring Together’ series, we interviewed Lusi Chien – Former Global Commercial Leader at Subtle Medical – about her role, what inspired her to join the medtech industry and why you should treat your career like a VC treats its investments.
Read more
What Will 2021 Hold for the US Dental Industry?
What Will 2021 Hold for the US Dental Industry?
by Team Invenia Life Sciences
Posted in MedTech & Devices
Like many sectors, 2020 was a challenging year for the US dental industry, with widespread temporary closures of dental practices and over 90% of US dentists applying for relief during the pandemic. But what will 2021 hold? I spoke to senior leaders across the US dental industry to determine the top trends driving the sector.
Read more
Covid-19 and the Pharma Supply Chain: Lasting Impacts for Generics and Biosimilars
Covid-19 and the Pharma Supply Chain: Lasting Impacts for Generics and Biosimilars
by Team Invenia Biopharma
Posted in Biopharma
The emergence of covid-19 and resulting lockdowns sparked fears for the global supply of generics and biosimilars. With the industry being heavily reliant on China for APIs and India for the manufacture of generic drugs, the disruption caused by covid-19 had the potential to wreak havoc across the whole supply chain.
Read more